GABARAPL2 and type 2 diabetes mellitus: We found that the levels of EIF2AK3, WIPI1, GABARAPL2, GAPDH, HSPA5, ITPR1, LAMP2, RAB7A, and RB1CC1 were decreased, while the expression of FOXO3 was increased in T2DM samples (Figure 6C).